Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TRLV · against 391 other Healthcare companies of similar size
Ranked #229 of 392 · scores higher than 42% of peers · safety percentile 43
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)40 peers with a safety percentile of 40–49, including TRLV · Click a bar to see the companies
A mix: stronger current ratio, but weaker beta and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TRLV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 370 reported | 0.75× | 0.23× | 21% | 33% | |
| BetaLower is better · 371 reported | 1.76 | 0.58 | 8% | 33% | |
| Current ratioHigher is better · 377 reported | 5.94× | 2.78× | 77% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 1.2B USD | 99 | ||
| 225 | 17.9B CNY (≈$2.5B) | 45 | 62 | |
| 226 | 16.5B CNY (≈$2.3B) | 45 | 57 | |
| 227 | 13.8B CNY (≈$1.9B) | 45 | 51 | |
| 228 | 26.6B CNY (≈$3.7B) | 44 | 57 | |
| 229 | 2.2B USD | 43 | 23 | |
| 230 | 16.3B CNY (≈$2.3B) | 43 | 49 | |
| 231 | 2.8B USD | 43 | 22 | |
| 232 | 2.2B USD | 43 | 61 | |
| 233 | 1.5B EUR (≈$1.7B) | 42 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score